| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078630 Method for the production of flavonoid-containing compositions and use thereof |
| 04/13/2006 | US20060078595 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 04/13/2006 | US20060078582 Use of compositions for treating rosacea |
| 04/13/2006 | US20060078568 Use of the residues from wine production |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | US20060078543 Neural progenitor cells derived from embryonic stem cells |
| 04/13/2006 | DE10320633B4 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von lebenden Zellen, die einem Reiz ausgesetzt wurden, und lebenden Zellen, die nicht diesem Reiz ausgesetzt wurden A method of identifying a possible modification of at least one biological parameter using living cells that were exposed to a stimulus, and living cells that were not exposed to this stimulus |
| 04/13/2006 | DE102004048877A1 New tricyclic thiazole derivatives useful as PI3 kinase inhibitors, for treating e.g. inflammatory and allergic airway and skin diseases, autoimmune and kidney disease |
| 04/13/2006 | DE10002304B4 Verwendung der 1,1-Dioxo-perhydro-1,2,4-thiadiazine Taurolidin oder Taurultam zur Behandlung von Neurodermitis Use of 1,1-dioxo-perhydro-1,2,4-thiadiazines taurolidine or taurultam for the treatment of atopic dermatitis |
| 04/13/2006 | CA2582974A1 Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods |
| 04/13/2006 | CA2582683A1 Novel antibodies directed to the mammalian eag1 ion channel protein |
| 04/13/2006 | CA2582607A1 Compositions and methods for inducing melanogenesis in a subject |
| 04/13/2006 | CA2582327A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/12/2006 | EP1645624A1 Nerve cells obtained by electrical pulse treatment es cell |
| 04/12/2006 | EP1645288A1 New nuclear transcription factors regulators |
| 04/12/2006 | EP1645267A2 Method for producing an active ingredient concentrate and active ingredient concentrate |
| 04/12/2006 | EP1644318A1 New method for synthesizing ceramide-type compounds |
| 04/12/2006 | EP1644033A2 Use of inhibitors of enzymes with aminopeptidase n and/or dipeptidylpeptidase iv activity and pharmaceutical preparations of said inhibitors for the treatment and prevention of dermatological diseases involving the hyperproliferation and modified differentiation conditions of fibroblasts |
| 04/12/2006 | EP1644017A2 Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells |
| 04/12/2006 | EP1644009A2 Compositions and methods for increasing telomerase activity |
| 04/12/2006 | EP1643990A1 Metronidazole-based green tinted topical pharmaceutical composition |
| 04/12/2006 | EP1643971A2 Liposomal formulations comprising a combination of two or more active agents |
| 04/12/2006 | EP1643965A2 Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin |
| 04/12/2006 | EP1423436B1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 04/12/2006 | EP1409513B1 Methylene-4-azasteroids |
| 04/12/2006 | EP1404174A4 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/12/2006 | EP1343771B1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 04/12/2006 | EP1331940B1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1200040B1 Two-component composition for cosmetic or pharmaceutical use |
| 04/12/2006 | EP1191922B1 Composition based on fluorinated polymer and alpha-hydroxy-acid salt for topical use for skin protection |
| 04/12/2006 | EP1146851B1 Galenic formulation containing biotin |
| 04/12/2006 | EP1144435B1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2006 | EP1140175B1 Antibodies to truncated vegf-d and uses thereof |
| 04/12/2006 | EP1071431B1 Cosmetic formulations comprising bis(triorganosilyl)hydroxycarboxylic acid derivatives |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | EP1041880A4 A delivery of arginine to cause beneficial effects |
| 04/12/2006 | EP0972042B1 Polypeptide expressed in the horny layer of epidermis and use thereof |
| 04/12/2006 | EP0938328B1 Method of inhibiting fibrosis with a somatostatin agonist |
| 04/12/2006 | CN1757412A Prescription of hair-nourishing and hair black preparation, and prepn. method |
| 04/12/2006 | CN1757406A Traditional Chinese medicine composition for treating burns and scald |
| 04/12/2006 | CN1757392A Cream for treating dexmatosis, and its prepn. method |
| 04/12/2006 | CN1250548C Novel adenine derivatives |
| 04/12/2006 | CN1250544C Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods |
| 04/12/2006 | CN1250526C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 04/12/2006 | CN1250288C Beta glycan as an inhibin receptor and uses thereof |
| 04/12/2006 | CN1250287C Application of recombinant adenovirus in treating cerebral ischemia, traumatic restoration and tissue adhesion |
| 04/12/2006 | CN1250280C Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 04/12/2006 | CN1250260C Medicine against psoriasis |
| 04/12/2006 | CN1250259C Liquid medicine for treating burns |
| 04/12/2006 | CN1250258C Usage of one-ingredient fleur root high wine soak liquid |
| 04/12/2006 | CN1250254C Medicine for promoting wound healing |
| 04/12/2006 | CN1250229C Transdermic administrated external-use medicine composition |
| 04/12/2006 | CN1250225C Use of 2alpha-methyl-19-nor-20(s)-1alpha, 25-dihydroxyvitamin d3 to increase bone strength |
| 04/12/2006 | CN1250207C 4, 4-diaryl butadienes compound and use of ultraviolet-ray filtering agent |
| 04/12/2006 | CN1250204C Physical stable spraying gel composition |
| 04/12/2006 | CN1250202C Foaming cosmetic paste |
| 04/11/2006 | US7026510 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/11/2006 | US7026484 For therapy of cancer |
| 04/11/2006 | US7026476 Intermediate arylamine compounds |
| 04/11/2006 | US7026462 Regulation of angiogenesis with zinc finger proteins |
| 04/11/2006 | US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 04/11/2006 | US7026326 Substituted heterocyclic compounds and methods of use |
| 04/11/2006 | US7026319 Use of vitamin combination for the treatment of pruritus and non-infective disorders involving itching and/or inflammation |
| 04/11/2006 | US7025973 Acid cosmetic, dermatological and pharmaceutical agents |
| 04/11/2006 | CA2321177C Recombinant fibronectin-based extracellular matrix for wound healing |
| 04/11/2006 | CA2282840C S-2'-(2-(1-methyl-2-piperidyl) ethyl) cinnamanilide as a 5-ht2 receptor antagonist |
| 04/06/2006 | WO2006036031A1 Fused furan derivative and use thereof |
| 04/06/2006 | WO2006035954A1 Carbostyril compound |
| 04/06/2006 | WO2006035900A1 Coenzyme q10-containing emulsified composition |
| 04/06/2006 | WO2006035760A1 Drug for treating skin disease |
| 04/06/2006 | WO2006035700A1 Composition containing proanthocyanidin and sphingolipid |
| 04/06/2006 | WO2006035225A1 Clostridial neurotoxins for use in tissue healing |
| 04/06/2006 | WO2006034968A1 Photo-stable cosmetic or dermatological compositions |
| 04/06/2006 | WO2006018024A3 Cosmetic and pharmaceutical compositions comprising ace inhibitors and/or angiotensin ii receptor antagonists |
| 04/06/2006 | WO2005100373A3 Monosaccharide derivatives as anti-cancer and anti-inflammatory agents |
| 04/06/2006 | WO2005082386A3 Manganese and iron based compounds for elastogenesis and connective tissue treatment |
| 04/06/2006 | US20060074244 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 04/06/2006 | US20060074129 Method for obtaining ozonized oils and vegetable fats and use of said products for pharmaceutical and cosmetic purposes |
| 04/06/2006 | US20060074125 Novel dithiolopyrrolones with therapeutic activity |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074114 Methods of reducing serum glucose and triglyceride levels and for inhibiting angiogenesis using substituted indolealkanoic acids |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/06/2006 | US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/06/2006 | US20060074106 Treatment of inflammatory disorders |
| 04/06/2006 | US20060074096 anti-cell prolifertive agents; 4-(1,2-diethylimidazol-5-yl)-2-{4-[N-(2-ethoxyethyl)sulphamoyl]anilino}pyrimidine; cancers, solid tumours, leukemias, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, hemangioma, nephropathies, atheroma, atherosclerosis, restenosis, autoimmune diseases, inflammation |
| 04/06/2006 | US20060074058 Combination of dpp iv inhibitor and a cardiovascular compound |
| 04/06/2006 | US20060073567 Novel insulin/IGF/relaxin family polypeptides and DNAs thereof |
| 04/06/2006 | US20060073162 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 04/06/2006 | US20060073114 Compounds and methods to inhibit or augment an inflammatory response |
| 04/06/2006 | DE10231370B4 Thiophenglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Thiophenglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 04/06/2006 | DE102004034747A1 Ointment preparation, useful e.g. for the preparation of a cosmetic and/or pharmaceutical agents for the treatment of skin, comprises an ointment basis (e.g. vaseline) and active substance components (e.g. dexpanthenol) |
| 04/06/2006 | DE102004034493A1 Pharmaceutical and/or cosmetic preparations, useful to treat e.g. skin, gastro-intestinal and infectious disease, comprising an extract from Quercus coccifera root and optionally an auxiliary or additives |
| 04/06/2006 | CA2581769A1 Methods of using chimeric coiled-coil molecule |
| 04/06/2006 | CA2581606A1 Carrier-free composition for the treatment of onychomycosis |
| 04/06/2006 | CA2580811A1 Carbostyril compound |